Ezetimibe binds to glucosinolates mainly in the small intestine and liver and is subsequently excreted from the intestine by bile and metabolized by the kidneys.
Ezetimibe Tablet can inhibit the absorption of cholesterol in the small intestine to reduce the cholesterol level in the blood, and is mainly used in the treatment of hypercholesterolemia. After oral absorption, the product combines with glucosinolates to form the pharmacologically active ezetimibe-glucosinolates, which are subsequently metabolized and excreted mainly by the bile and kidneys.
Adverse effects of this product include abdominal pain, diarrhea, intestinal gas and bloating, fatigue, etc. It is contraindicated in those who are allergic to this product. It is important to note that this product, in combination with HMG-CoA reductase inhibitors, is contraindicated in patients with active liver disease, or unexplained persistent elevation of serum transaminases.
Please use the drug under the guidance of a physician, and not blindly use the drug on your own.